Keith Kendall
CEO
CEO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Aquestive Therapeutics, Inc. (AQST) | Chief Executive Officer | $550,000 | $2,049,198 |
| 2020 | Aquestive Therapeutics, Inc. (AQST) | Chief Executive Officer | $550,000 | $1,290,418 |
| 2019 | Aquestive Therapeutics, Inc. (AQST) | Chief Executive Officer | $540,385 | $2,628,576 |
Earnings-call appearances
-
Aquestive Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-04
Aquestive Therapeutics, Inc. (AQST)
-
Aquestive Therapeutics, Inc. Q4 FY2021 Earnings Call2022-03-08
Aquestive Therapeutics, Inc. (AQST)
-
Aquestive Therapeutics, Inc. Q3 FY2021 Earnings Call2021-11-02
Aquestive Therapeutics, Inc. (AQST)
-
Aquestive Therapeutics, Inc. Q2 FY2021 Earnings Call2021-08-03
Aquestive Therapeutics, Inc. (AQST)
-
Aquestive Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-04
Aquestive Therapeutics, Inc. (AQST)
-
Aquestive Therapeutics, Inc. Q4 FY2020 Earnings Call2021-03-09
Aquestive Therapeutics, Inc. (AQST)
-
Aquestive Therapeutics, Inc. Q3 FY2020 Earnings Call2020-11-04
Aquestive Therapeutics, Inc. (AQST)
-
Aquestive Therapeutics, Inc. Q2 FY2020 Earnings Call2020-08-04
Aquestive Therapeutics, Inc. (AQST)
-
Aquestive Therapeutics, Inc. Q1 FY2020 Earnings Call2020-05-05
Aquestive Therapeutics, Inc. (AQST)